John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Gogo Inc
GOGO
$363M
| $21.9M | 0.06% |
1,150,810
-297,446
| -21% | -$4.35M |
|
352
TriNet
TNET
$3.24B
| $21.9M | 0.06% |
222,995
+42,004
| +23% | +$3.71M |
|
353
Nordson
NDSN
$18.5B
| $21.8M | 0.06% |
96,035
+46,819
| +95% | +$10.8M |
|
354
STMicroelectronics
STM
$45.1B
| $21.7M | 0.06% |
501,605
+486,822
| +3,293% | +$21.5M |
|
|
GOOS
355
Canada Goose Holdings
GOOS
$854M
| $21.6M | 0.06% |
819,829
+774,922
| +1,726% | +$22.2M |
|
356
Macerich
MAC
$6.91B
| $21.4M | 0.06% |
1,369,956
+1,040,371
| +316% | +$16.7M |
|
|
AAWW
357
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $21.3M | 0.06% |
247,013
+240,330
| +3,596% | +$19.7M |
|
358
Sprout Social
SPT
$607M
| $21.3M | 0.06% |
265,613
-18,827
| -7% | -$1.29M |
|
359
Tapestry
TPR
$26B
| $21.2M | 0.06% |
571,668
-883,605
| -61% | -$33.9M |
|
|
HDV
360
iShares Core High Dividend ETF
HDV
$15.3B
| $21.2M | 0.06% |
990,760
+148,000
| +18% | +$3.07M |
|
361
Exelixis
EXEL
$13.4B
| $21.1M | 0.06% |
928,561
+228,173
| +33% | +$4.46M |
|
|
FTCH
362
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $20.9M | 0.06% |
+1,379,808
| New | +$26.7M |
|
363
Cameco
CCJ
$44.6B
| $20.8M | 0.06% |
714,824
-2,302,177
| -76% | -$54M |
|
364
MGIC Investment
MTG
$6.34B
| $20.8M | 0.06% |
1,532,034
+1,481,029
| +2,904% | +$22.2M |
|
365
ExxonMobil
XOM
$679B
| $20.7M | 0.06% |
251,046
-1,419,152
| -85% | -$110M |
|
366
Ralph Lauren
RL
$22.2B
| $20.7M | 0.06% |
182,728
+65,923
| +56% | +$7.77M |
|
367
Republic Services
RSG
$67.6B
| $20.6M | 0.06% |
155,819
-520,116
| -77% | -$66.1M |
|
|
NEX
368
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $20.6M | 0.06% |
2,225,781
+1,761,492
| +379% | +$12.6M |
|
369
Invesco S&P 500 Low Volatility ETF
SPLV
$7.07B
| $20.6M | 0.06% |
306,500
-1,116,800
| -78% | -$72.7M |
|
370
Coeur Mining
CDE
$21.6B
| $20.4M | 0.06% |
4,576,851
+2,808,491
| +159% | +$13.4M |
|
371
CALL
PG&E
PCG
$38.8B
| $20.3M | 0.06% |
1,696,600
-26,000
| -2% | -$307K |
|
372
CRISPR Therapeutics
CRSP
$5.75B
| $20M | 0.06% |
318,374
+105,790
| +50% | +$6.64M |
|
373
Lincoln Electric
LECO
$15.4B
| $19.9M | 0.06% |
144,755
+113,107
| +357% | +$14.8M |
|
|
MAXR
374
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $19.9M | 0.06% |
503,765
+230,623
| +84% | +$7.05M |
|
375
Toll Brothers
TOL
$13.7B
| $19.8M | 0.06% |
421,299
+38,833
| +10% | +$2.18M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.